| |
| |
|
| Insider
Information: |
Steinman Lawrence |
| Relationship: |
Director |
| City: |
Stanford |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,687,667 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,326,809 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,687,667 |
|
|
| Total
Value |
$2,326,809 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
| Percentage
Gain/Loss : |
 -80.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Director |
2005-03-02 |
15,500 |
2004-09-15 |
0 |
Premium* |
|
|
Atreca Inc |
BCEL |
Director |
2019-06-24 |
258,405 |
|
0 |
Premium* |
|
|
180 Life Sciences Corp |
ATNF |
Director |
2023-06-01 |
48,129 |
|
0 |
Premium* |
|
|
Bioatla, Inc. |
BCAB |
Director |
2023-12-19 |
38,459 |
|
0 |
Premium* |
|
|
Pasithea Therapeutics Corp. |
KTTA |
Director |
2023-06-02 |
1,327,174 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2023-12-19 |
4 |
B |
$2.05 |
$41,048 |
D/D |
20,000 |
38,459 |
2.39 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2023-06-02 |
4 |
B |
$0.43 |
$12,930 |
D/D |
30,000 |
1,327,174 |
2.39 |
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2023-06-01 |
4 |
B |
$1.23 |
$22,068 |
D/D |
18,000 |
48,129 |
2.39 |
% |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2022-11-28 |
4 |
A |
$0.98 |
$4,900 |
D/D |
5,000 |
1,287,174 |
0 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2022-11-22 |
4 |
A |
$0.99 |
$4,950 |
D/D |
5,000 |
1,282,174 |
0 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2022-10-26 |
4 |
A |
$1.10 |
$5,500 |
D/D |
5,000 |
1,277,174 |
0 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2022-10-17 |
4 |
A |
$1.13 |
$11,310 |
D/D |
10,000 |
1,272,174 |
0 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2022-06-29 |
4 |
A |
$1.00 |
$5,000 |
D/D |
5,000 |
1,272,174 |
0 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2022-06-28 |
4 |
A |
$1.02 |
$5,100 |
D/D |
5,000 |
1,267,174 |
0 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2022-06-27 |
4 |
A |
$1.00 |
$5,000 |
D/D |
5,000 |
1,262,174 |
0 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2022-06-23 |
4 |
A |
$1.00 |
$5,000 |
D/D |
5,000 |
1,257,174 |
0 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2022-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
652,174 |
1,252,174 |
0 |
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2021-12-09 |
4 |
B |
$4.27 |
$21,350 |
D/D |
5,000 |
602,574 |
2.39 |
% |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2021-11-02 |
4 |
AS |
$30.00 |
$13,500 |
D/D |
(450) |
18,459 |
0 |
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2021-09-30 |
4 |
A |
$6.00 |
$31,296 |
D/D |
5,216 |
597,574 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2021-09-15 |
4 |
AS |
$36.82 |
$16,569 |
D/D |
(450) |
18,909 |
0 |
- |
|
| KTTA |
Pasithea Therapeutics Cor... |
Director |
– • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
600,000 |
|
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2021-08-16 |
4 |
AS |
$40.60 |
$18,270 |
D/D |
(450) |
19,359 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2021-07-15 |
4 |
AS |
$38.29 |
$17,231 |
D/D |
(450) |
19,809 |
0 |
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2021-04-07 |
4 |
A |
$6.14 |
$138,672 |
D/D |
22,585 |
592,358 |
0 |
- |
|
| BCAB |
Bioatla, Inc. |
Director |
– • – |
2020-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,871 |
|
- |
|
| ATNF |
180 Life Sciences Corp |
Director |
– • – |
2020-11-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
569,773 |
|
% |
|
| BCEL |
Atreca Inc |
Director |
– • – |
2019-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
8,405 |
258,405 |
0 |
- |
|
| BCEL |
Atreca Inc |
Director |
– • – |
2019-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250,000 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2005-03-02 |
4 |
S |
$41.09 |
$164,406 |
D/D |
(4,000) |
15,500 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
